glutamic acid has been researched along with Thyroid Cancer, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bishop, J; Du, J; El-Naggar, AK; Liu, R; Liu, X; Luo, Y; Qu, S; Shan, Z; Shi, X; Sun, H; Teng, W; Wang, E; Xing, M; Yang, X; Zhao, J; Zhu, G | 1 |
Hodin, R; Lawler, J; Nucera, C; Parangi, S | 1 |
1 review(s) available for glutamic acid and Thyroid Cancer, Anaplastic
Article | Year |
---|---|
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
Topics: Amino Acid Substitution; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Transformation, Neoplastic; Glutamic Acid; Humans; Models, Biological; Mutation, Missense; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valine | 2010 |
1 other study(ies) available for glutamic acid and Thyroid Cancer, Anaplastic
Article | Year |
---|---|
Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Amino Acid Substitution; Epistasis, Genetic; Female; Genetic Association Studies; Glutamic Acid; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Telomerase; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valine | 2015 |